Skip to content

Company History

Organic Growth, Since 2002

Brightech’s history goes back to 2002, when Dr. Tai Xie started the company, performing work for Imclone and then Novartis.

Since then, Brightech has grown organically, to 126 employees globally, with 100+ clients and 400+ completed projects in all phases. Brightech has been involved in over 30 NDA submissions, 6 obtained FDA/EMA approval.

Brightech has completed

  • Statistics and SAS programming for 400+ phase I-IV studies
  • Data management in the US and China for 250+ phase I-III studies
  • ISS/ISE for NDA/BLA submissions (5 NDA approvals)
  • Patient profiles for 60 studies
  • SDTM, ADaM and define.pdf, define.xml for over 100 studies
  • Clinical operations in the US and China for 30+ studies
  • Protocol deviation checks via SAS programming for 45 studies
  • Medical writing (CSR, IB, ISS) for 10+ studies

Despite this growth, Dr. Xie still handles client relationships. Building a partner-like relationship is important to Dr. Xie, who promises to quality, efficiency and completeness for every client project.

This commitment, and personal oversight, has delivered a 95% client retention rate.